SCM

Suvretta Capital Management Portfolio holdings

AUM $4.01B
1-Year Est. Return 66.2%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+66.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.3B
AUM Growth
+$644M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
106
New
Increased
Reduced
Closed

Top Buys

1 +$49.2M
2 +$31.6M
3 +$30.3M
4
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$28.2M
5
FERG icon
Ferguson
FERG
+$26.4M

Top Sells

1 +$60.4M
2 +$39.4M
3 +$28.8M
4
DDOG icon
Datadog
DDOG
+$24M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$16.7M

Sector Composition

1 Healthcare 60.44%
2 Technology 13.51%
3 Consumer Discretionary 5.97%
4 Financials 5.68%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
76
McKesson
MCK
$120B
$1.41M 0.04%
1,830
IQV icon
77
IQVIA
IQV
$29.5B
$1.36M 0.04%
7,175
HCA icon
78
HCA Healthcare
HCA
$122B
$1.36M 0.04%
3,190
GLPG icon
79
Galapagos
GLPG
$2.22B
$1.29M 0.04%
37,111
WAT icon
80
Waters Corp
WAT
$30.6B
$944K 0.03%
3,150
AVTR icon
81
Avantor
AVTR
$5.9B
$897K 0.03%
71,850
EW icon
82
Edwards Lifesciences
EW
$49.5B
$863K 0.03%
11,100
IONS icon
83
Ionis Pharmaceuticals
IONS
$12.9B
$707K 0.02%
10,800
RMD icon
84
ResMed
RMD
$37.6B
$654K 0.02%
2,390
A icon
85
Agilent Technologies
A
$34.1B
$640K 0.02%
4,990
VLTO icon
86
Veralto
VLTO
$23.7B
$584K 0.02%
5,475
STE icon
87
Steris
STE
$23.8B
$379K 0.01%
1,530
SRPT icon
88
Sarepta Therapeutics
SRPT
$1.69B
$345K 0.01%
17,888
ZBH icon
89
Zimmer Biomet
ZBH
$19.2B
$321K 0.01%
3,260
PACS icon
90
PACS Group
PACS
$5.69B
$275K 0.01%
20,000
ALGN icon
91
Align Technology
ALGN
$13.1B
-1,100
BAX icon
92
Baxter International
BAX
$9.79B
-7,970
CRH icon
93
CRH
CRH
$75.9B
-8,460
CZR icon
94
Caesars Entertainment
CZR
$5.2B
-18,875
DDOG icon
95
Datadog
DDOG
$41.7B
-178,832
GEHC icon
96
GE HealthCare
GEHC
$36B
-532,280
IWM icon
97
iShares Russell 2000 ETF
IWM
$74.1B
0
KYMR icon
98
Kymera Therapeutics
KYMR
$6.91B
-275,000
MRNA icon
99
Moderna
MRNA
$22.8B
-517,163
PEPG icon
100
PepGen
PEPG
$465M
-300,000